Zobrazeno 1 - 10
of 1 414
pro vyhledávání: '"Sheppard KE"'
Autor:
Spahillari A; Department of Medicine (Division of Cardiology), Duke University School of Medicine, Durham, North Carolina, USA., Cohen LP; Department of Medicine (Division of Cardiology), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lin C; Department of Medicine (Division of Cardiology), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Liu Y; Department of Medicine (Division of Cardiology), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Tringale A; Department of Medicine (Division of Cardiology), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sheppard KE; Department of Medicine (Division of Cardiology), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ko C; Department of Medicine (Division of Cardiology), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Khairnar R; Novartis Pharmaceuticals Corp, East Hanover, New Jersey, USA., Williamson KM; Novartis Pharmaceuticals Corp, East Hanover, New Jersey, USA., Wasfy JH; Department of Medicine (Division of Cardiology), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Scott NS; Department of Medicine (Division of Cardiology), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Paquette C; Department of Medicine (Division of Cardiology), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Greene SJ; Department of Medicine (Division of Cardiology), Duke University School of Medicine, Durham, North Carolina, USA; Duke Clinical Research Institute, Durham, North Carolina, USA., Fonarow GC; Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, California, USA., Januzzi JL Jr; Department of Medicine (Division of Cardiology), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Baim Institute for Clinical Research, Boston, Massachusetts, USA. Electronic address: jjanuzzi@mgb.org.
Publikováno v:
JACC. Heart failure [JACC Heart Fail] 2024 Oct 09. Date of Electronic Publication: 2024 Oct 09.
Autor:
Chan LH; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Wang P; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Abuhammad S; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Lim LRJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Cursons J; Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia., Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, Victoria, Australia., Goode DL; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
Publikováno v:
PloS one [PLoS One] 2023 Nov 02; Vol. 18 (11), pp. e0292278. Date of Electronic Publication: 2023 Nov 02 (Print Publication: 2023).
Publikováno v:
Cancer Management and Research, Vol 2013, Iss default, Pp 281-292 (2013)
Maressa A Bruhn,1,6 Richard B Pearson,1–4 Ross D Hannan,1–5 Karen E Sheppard1–3 1Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; 2Sir Peter MacCallum Department of Oncology, 3Department of Biochemistr
Externí odkaz:
https://doaj.org/article/191070c2e8204ac29cba18c9a70b9815
Autor:
Patel RP; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Somasundram PM; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia., Smith LK; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Publikováno v:
Clinical and translational medicine [Clin Transl Med] 2023 Mar; Vol. 13 (3), pp. e1197.
Autor:
Prabhu SA; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Moussa O; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Gonçalves C; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., LaPierre JH; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Chou H; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Huang F; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada., Ferruzo PYM; Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada., Guettler EM; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Soria-Bretones I; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Kirby L; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Gagnon N; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Su J; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Silvester J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Krisna SS; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Rose AAN; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada., Sheppard KE; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia., Cescon DW; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada., Mallette FA; Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada.; Department of Medicine, Université de Montréal, Montréal, Québec, Canada., Zahedi RP; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada., Del Rincon SV; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada., Miller WH; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2023 Feb 01; Vol. 22 (2), pp. 192-204.
Autor:
Lelliott EJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Mangiola S; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Ramsbottom KM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Zethoven M; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Lim L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Lau PKH; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Oliver AJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Martelotto LG; Single Cell Innovation Laboratory, The University of Melbourne, Parkville, Victoria, Australia., Kirby L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Martin C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Patel RP; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Slater A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Cullinane C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Papenfuss AT; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Haynes NM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Oliaro J; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. karen.sheppard@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2021 Feb; Vol. 9 (2), pp. 136-146. Date of Electronic Publication: 2020 Dec 10.
Autor:
Lelliott EJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. emily.lelliott@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia. emily.lelliott@petermac.org., Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC, Australia., McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2022 Apr 20; Vol. 6 (1), pp. 26. Date of Electronic Publication: 2022 Apr 20.
Autor:
Smith LK; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia. lorey.smith@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. lorey.smith@petermac.org., Parmenter T; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia., Kleinschmidt M; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia., Kusnadi EP; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia., Kang J; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia., Martin CA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia., Lau P; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Patel R; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Lorent J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Papadopoli D; Lady Davis Institute for Medical Research and Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada., Trigos A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia., Ward T; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia., Rao AD; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Lelliott EJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Australia., Goode D; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Hicks RJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Tiganis T; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia., Simpson KJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Larsson O; Lady Davis Institute for Medical Research and Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada., Blythe B; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia., Cullinane C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Wickramasinghe VO; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Pearson RB; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Australia., McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia. grant.mcarthur@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. grant.mcarthur@petermac.org.; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Melbourne, Australia. grant.mcarthur@petermac.org.
Publikováno v:
Nature communications [Nat Commun] 2022 Mar 01; Vol. 13 (1), pp. 1100. Date of Electronic Publication: 2022 Mar 01.
Autor:
Lau PKH; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Cullinane C; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Jackson S; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Walker R; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Smith LK; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Slater A; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Kirby L; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Patel RP; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., von Scheidt B; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Slaney CY; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., McArthur GA; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Sheppard KE; Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.; Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, VIC 3010, Australia.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Dec 17; Vol. 13 (24). Date of Electronic Publication: 2021 Dec 17.
Autor:
Alkaraki A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia., Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC 3010, Australia., Smith LK; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Nov 19; Vol. 13 (22). Date of Electronic Publication: 2021 Nov 19.